Does once-monthly oral ibandronate improve biomechanical determinants of bone strength in women with postmenopausal osteoporosis?
Once-monthly oral Ibandronate for 12 months improved hip and spine BMD measured by QCT and DXA and strength estimated by FEA of QCT scans.
These compounds are promising candidates to be used as disinfectants in hospital settings.